Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited

被引:30
作者
Friederichs, K [1 ]
Schmitz, J [1 ]
Weissenbach, M [1 ]
Heinrich, PC [1 ]
Schaper, F [1 ]
机构
[1] Rhein Westfal TH Aachen, Inst Biochem, Dept Biochem, D-52074 Aachen, Germany
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 24期
关键词
interleukin-6; SHP2; gp130; SOCS3; proliferation;
D O I
10.1046/j.0014-2956.2001.02586.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL-6) induces B-cell proliferation by binding to receptor complexes composed of a specific alpha -receptor (gp80; CD126) and the signal transducing receptor subunit gp130 (CD130). Immediately after receptor complex activation, signal transducers and activators of transcription (STATs) 1 and 3 and the Src-homology domain-containing protein tyrosine phosphatase 2 (SHP2) are recruited to gp130 and subsequently tyrosine phosphorylated. The activated dimerized STATs translocate to the nucleus and bind to enhancer elements of IL-6-inducible genes. SHP2 acts as an adapter and links the Jak/STAT pathway to the Ras/Raf/MAPK cascade but it is also involved in signal attenuation. Whereas STAT3 activation appears to be crucial for all biological activities of IL-6, the requirement of SHP2-activation depends on the individual biological response analyzed. The requirement of SHP2 activation for the pre-B cell (Ba/F3) proliferation has been reported previously [Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. & Hirano, T. (1996) Immunity 5, 449-460]. In contrast, we have recently demonstrated that the presence of a single STAT-recruitment site within gp130 is sufficient for IL-6- induced proliferation of Ba/F3 cells [Schmitz, J., Dahmen, H., Grimm, C., Gendo, C., Muller-Newen, G., Heinrich, P.C. & Schaper, F. (2000) J. Immunol. 164, 848-854]. To unravel this discrepancy we analyzed the IL-6-induced dose-dependent proliferation of Ba/F3 cells mediated by receptor complexes lacking SHP2/SOCS3 recruitment sites. Surprisingly, pre-B cells, after stimulation with low amounts of IL-6, proliferate much more efficiently in the absence of the activated SHP2 than in the presence of the tyrosine phosphatase. Therefore, SHP2 activation appears to be relevant for IL-6-induced proliferation only after stimulation with very large amounts of IL-6.
引用
收藏
页码:6401 / 6407
页数:7
相关论文
共 29 条
  • [1] Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: Structural receptor requirements for signal attenuation
    Anhuf, D
    Weissenbach, M
    Schmitz, J
    Sobota, R
    Hermanns, HM
    Radtke, S
    Linnemann, S
    Behrmann, I
    Heinrich, PC
    Schaper, F
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (05) : 2535 - 2543
  • [2] Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras
    Cacalano, NA
    Sanden, D
    Johnston, JA
    [J]. NATURE CELL BIOLOGY, 2001, 3 (05) : 460 - 465
  • [3] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [4] Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
    Fukada, T
    Hibi, M
    Yamanaka, Y
    TakahashiTezuka, M
    Fujitani, Y
    Yamaguchi, T
    Nakajima, K
    Hirano, T
    [J]. IMMUNITY, 1996, 5 (05) : 449 - 460
  • [5] STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition
    Fukada, T
    Ohtani, T
    Yoshida, Y
    Shirogane, T
    Nishida, K
    Nakajima, K
    Hibi, M
    Hirano, T
    [J]. EMBO JOURNAL, 1998, 17 (22) : 6670 - 6677
  • [6] Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells
    Gatsios, P
    Haubeck, HD
    vandeLeur, E
    Frisch, W
    Apte, SS
    Greiling, H
    Heinrich, PC
    Graeve, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (01): : 56 - 63
  • [7] Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
    Heinrich, PC
    Behrmann, I
    Müller-Newen, G
    Schaper, F
    Graeve, L
    [J]. BIOCHEMICAL JOURNAL, 1998, 334 : 297 - 314
  • [8] BIOLOGICAL AND CLINICAL ASPECTS OF INTERLEUKIN-6
    HIRANO, T
    AKIRA, S
    TAGA, T
    KISHIMOTO, T
    [J]. IMMUNOLOGY TODAY, 1990, 11 (12): : 443 - 449
  • [9] Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6)center dot IL-6 receptor center dot gp130 complex
    Horsten, U
    MullerNewen, G
    Gerhartz, C
    Wollmer, A
    Wijdenes, J
    Heinrich, PC
    Grotzinger, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) : 23748 - 23757
  • [10] Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6
    Ihara, S
    Nakajima, K
    Fukada, T
    Hibi, M
    Nagata, S
    Hirano, T
    Fukui, Y
    [J]. EMBO JOURNAL, 1997, 16 (17) : 5345 - 5352